PMDA drug package insert

ボルタレンテープ15mg

PMDA Prescription drug · 同仁医薬化工株式会社 · package insert Mar 31, 2026

Key facts

Brand names ボルタレンテープ15mg, ボルタレンテープ30mg
Nonproprietary names ジクロフェナクナトリウム
Companies 製造販売/同仁医薬化工株式会社, 販売/ノバルティスファーマ株式会社
Product type Prescription drug
Therapeutic category 経皮鎮痛消炎剤
Therapeutic category codes 872649
YJ codes 2649734S1074, 2649734S2070
Approval numbers 22000AMX00653000, 22000AMX00708000
Package insert edition 第4版
Package insert date Mar 31, 2026
PMDA document key 471825_2649734S1074_2
PMDA company code 471825

At a glance

  • 1–9 Package insert revisions
  • 10–99 Related PMDA documents
  • 1–9 Safety communications
  • No PMDA review report published
  • No Risk management plan (RMP)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMDA approved drugs and package inserts (Japan)

Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.

Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date:

Browse all PMDA approved drugs and package inserts (Japan)